Ilaria Cutini

10PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingHaematological tumoursImmunogenetics (incl. genetic immunology)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 05, 2026
Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.

|Mar 02, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT.

Jan Styczynski, Gloria Tridello, Nina Knelange

|Jan 23, 2026
Downregulation of CD19 Expression Associates With Mantle Cell Lymphoma Relapse Following CAR-T Cell Therapy.

Benedetta Peruzzi, Alessio Mazzoni, Ilaria Cutini

|Aug 05, 2025
Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis.

Anna Dodero, Giusy Ceparano, Beatrice Casadei

|May 05, 2025
The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis.

Corrado Girmenia, Patrizia Chiusolo, Giovanni Marsili

|Dec 23, 2024
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study.

Federico Stella, Annalisa Chiappella, Martina Magni

Pageof 2

Frequent Collaborators

6 joint publications

Patrizia Chiusolo

4 joint publications

Mauro Krampera

4 joint publications

Francesca Bonifazi

4 joint publications

Federico Stella